Symposium

Cardiometabolic Medicines From the Gut: The Glucagon-Like Peptide Story

In honor of Daniel Drucker, Joel Habener, Jens Juul Holst

for identifying the family of Glucagon-Like Peptides through studies extending from cells to humans, culminating in the development of these peptides and related pathway-modifiers as important new classes of  therapeutic agents for treating diabetes, obesity and short bowel syndrome.

Featured Speakers Include:

Daniel Drucker, MD
Senior Scientist, the Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada,
Professor of Medicine, University of Toronto

Joel Habener, MD
Professor of Medicine, Harvard Medical School
Director of the Laboratory of Molecular Endocrinology, Massachusetts General Hospital

Jens Juul Holst, MD, DMSc
Professor of Biomedical Sciences, University of Copenhagen, Denmark

Invited Speakers Include:

Fiona Gribble, DPhil, BM, BCh
Professor of Endocrine Physiology
WT-MRC Institute of Metabolic Science
University of Cambridge

Matthias H. Tschöp, MD
Alexander von Humboldt Professor, Technical University of Munich
Chief Executive Officer and Scientific Director, Helmholtz Center Munich

Register here